Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Introduction: Previous studies on preoperative predictors of microvascular invasion (MVI) in intrahepatic cholangiocarcinoma (ICCA) have presented inconsistent results. This study aimed to identify preoperative clinical and magnetic resonance imaging (MRI) factors that can predict MVI in ICCA and to evaluate their prognostic utility using a multicenter cohort.

Methods: A multicenter cohort of 446 patients who underwent preoperative MRI and surgical resection for ICCA at six tertiary referral institutions between 2009 and 2018 was analyzed for clinical, pathologic, and MR imaging characteristics. Univariable and multivariable logistic regression analyses were performed to identify significant predictors of pathologically confirmed MVI, which were subsequently used to stratify patients into low-, intermediate-, and high-risk groups based on the number of predictors identified. Kaplan-Meier survival analysis and log-rank test were conducted to assess long-term survival and early recurrence among the three groups.

Results: Among the 446 patients (mean age, 63.0 ± 9.9 years; 277 men), 234 (52.5%) had MVI on pathology. Independent predictors of MVI included serum carbohydrate antigen 19-9 levels (≥80 U/mL; odds ratio [OR]: 2.68, 95% confidence interval [CI]: 1.64-4.37, < 0.001), tumor size (≥4 cm; OR: 1.60, 95% CI: 1.01-2.54, = 0.046), tumor multiplicity (OR: 2.84, 95% CI: 1.58-5.12, < 0.001), and arterial phase peritumoral enhancement (OR: 2.83, 95% CI: 1.81-4.42, < 0.001). Stratifying patients by MVI risk - low (no predictors), intermediate (1-3 predictors), and high (4 predictors) - revealed a significant decrease in both recurrence-free and overall survival rates ( < 0.001), along with a corresponding increase in early recurrence rates ( < 0.001) as the risk level increased.

Conclusion: Risk stratification utilizing four key predictors can effectively assess the risk of MVI in ICCA and is associated with postoperative outcomes.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12286615PMC
http://dx.doi.org/10.1159/000547071DOI Listing

Publication Analysis

Top Keywords

microvascular invasion
8
intrahepatic cholangiocarcinoma
8
predictors
8
mvi icca
8
446 patients
8
early recurrence
8
rates 0001
8
mvi
7
0001
5
preoperative
4

Similar Publications

Background: Postoperative late recurrence (POLAR) after 2 years from the date of surgical resection of hepatocellular carcinoma (HCC) represents a unique surveillance and management challenge. Despite identified risk factors, individualized prediction tools to guide personalized surveillance strategies for recurrence remain scarce. The current study sought to develop a predictive model for late recurrence among patients undergoing HCC resection.

View Article and Find Full Text PDF

Background: While the invasive index of microcirculation resistance (IMR) remains the gold standard for diagnosing coronary microvascular dysfunction (CMD), its clinical adoption is limited by procedural complexity and cost. Angiography-based IMR (Angio-IMR), a computational angiography-based method, offers a promising alternative. This study evaluates the diagnostic efficacy of Angio-IMR for CMD detection in angina pectoris (AP).

View Article and Find Full Text PDF

AI-informed retinal biomarkers predict 10-year risk of onset of multiple hematological malignancies.

Eur J Cancer

August 2025

Emory University, Atlanta, USA; Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA; Atlanta Veterans Administration Medical Center, Atlanta, USA. Electronic address:

Background: Early detection of hematological malignancies improves long-term survival but remains a critical challenge due to heterogeneity in clinical presentation. Chronic inflammation is a key driver in hematologic cancers and is known to induce compensatory microvascular changes. High-resolution, non-invasive retinal imaging can allow the quantification of microvascular changes for the early detection of hematological malignancies.

View Article and Find Full Text PDF

Validation of angiography-based FFR in non-culprit vessels of patients presenting with STEMI.

Clin Res Cardiol

September 2025

Department of (Interventional) Cardiology, Thoraxcenter, Erasmus University Medical Center, Room Rg-628, P.O. Box 2040, 3000 CA, Rotterdam, the Netherlands.

Background: Fractional flow reserve (FFR) for non-culprit lesions (NCLs) in patients with ST-elevation myocardial infarction (STEMI) can be influenced by temporary changes in microvascular resistance. Angiography-derived vessel fractional flow reserve (vFFR) has been tested as a less-invasive alternative.

Aims: The FAST STEMI II study aimed to assess the diagnostic performance of acute-setting vFFR vs.

View Article and Find Full Text PDF